The GSK-3β/β-catenin pathway has been reported to be involved in a variety of important cellular functions and is abnormally activated in a variety of malignancies, leading to tumor progression (Pan et al. 2021; Song et al. 2020). The gene discussed is GSK3B; the disease is neoplasm.